Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes

BACKGROUND AND OBJECTIVES: Doxorubicin, effective against many malignancies, is limited by cardiotoxicity. Continuous-infusion doxorubicin, compared with bolus-infusion, reduces early cardiotoxicity in adults. Its effectiveness in reducing late cardiotoxicity in children remains uncertain. We determ...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lipshultz, Steven E., Miller, Tracie L., Lipsitz, Stuart R., Neuberg, Donna S., Dahlberg, Suzanne E., Colan, Steven D., Silverman, Lewis B., Henkel, Jacqueline M., Franco, Vivian I., Cushman, Laura L., Asselin, Barbara L., Clavell, Luis A., Athale, Uma, Michon, Bruno, Laverdière, Caroline, Schorin, Marshall A., Larsen, Eric, Usmani, Naheed, Sallan, Stephen E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Academy of Pediatrics 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3507254/
https://ncbi.nlm.nih.gov/pubmed/23166343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2012-0727
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller